Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control
- PMID: 10754309
- DOI: 10.4049/jimmunol.164.8.4143
Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control
Abstract
Inhibition of class II trans-activator (CIITA) expression prevents embryonic trophoblast cells from up-regulating MHC class II genes in response to IFN-gamma. This is thought to be one mechanism of maternal tolerance to the fetal allograft. The CIITA gene is regulated by four distinct promoters; promoter III directs constitutive (B cell) expression, and promoter IV regulates IFN-gamma-inducible expression. Using in vivo genomic footprinting, promoter-reporter analysis, Southern blot analysis, and RT-PCR, we have examined the cause of CIITA silencing in a trophoblast-derived cell line. We report here that methylation of promoter IV DNA at CpG sites in Jar cells prevents promoter occupancy and IFN-gamma-inducible transcription. The inhibition of CpG methylation in Jar cells by treatment with 5-aza-2'-deoxycytidine restores IFN-gamma inducibility to CIITA. This is the first description of an epigenetic mechanism involved in regulation of CIITA and MHC class II gene expression.
Similar articles
-
Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.Biol Reprod. 2003 Sep;69(3):915-24. doi: 10.1095/biolreprod.103.017103. Epub 2003 May 14. Biol Reprod. 2003. PMID: 12748124
-
IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.J Immunol. 2001 Feb 15;166(4):2260-9. doi: 10.4049/jimmunol.166.4.2260. J Immunol. 2001. PMID: 11160280
-
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.J Immunol. 1999 Apr 15;162(8):4731-9. J Immunol. 1999. PMID: 10202014
-
Novel mechanisms of class II major histocompatibility complex gene regulation.Immunol Res. 2003;27(1):85-106. doi: 10.1385/IR:27:1:85. Immunol Res. 2003. PMID: 12637770 Review.
-
Regulation of transcription of MHC class II genes.Curr Opin Immunol. 1997 Feb;9(1):107-13. doi: 10.1016/s0952-7915(97)80166-5. Curr Opin Immunol. 1997. PMID: 9039770 Review.
Cited by
-
Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.J Exp Med. 2001 Aug 20;194(4):393-406. doi: 10.1084/jem.194.4.393. J Exp Med. 2001. PMID: 11514597 Free PMC article.
-
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.Leuk Lymphoma. 2009 Nov;50(11):1875-8. doi: 10.3109/10428190903297531. Leuk Lymphoma. 2009. PMID: 19814686 Free PMC article. No abstract available.
-
HLA-G gene repression is reversed by demethylation.Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1191-6. doi: 10.1073/pnas.0337539100. Epub 2003 Jan 27. Proc Natl Acad Sci U S A. 2003. PMID: 12552087 Free PMC article.
-
Chemical and genetic control of IFNγ-induced MHCII expression.EMBO Rep. 2018 Sep;19(9):e45553. doi: 10.15252/embr.201745553. Epub 2018 Jul 18. EMBO Rep. 2018. PMID: 30021835 Free PMC article.
-
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.Immunology. 2004 Jan;111(1):53-65. doi: 10.1111/j.1365-2567.2004.01783.x. Immunology. 2004. PMID: 14678199 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials